The 12 MSOs That Control American Cannabis (And What You Should Know About Each)

The word "industry" implies competition. Many companies producing similar products, competing for consumer dollars on price, quality, and brand. By that definition, American cannabis is not really an industry. It is a corporate footprint. Twelve multistate operators, by most analyses, control the majority of regulated cannabis revenue, retail location count, and political influence in the United States.

Knowing who they are matters. Whether you're a consumer choosing where to spend money, a worker considering employment, an entrepreneur evaluating partnerships, or a journalist trying to make sense of industry behavior, the names below shape what cannabis looks like in 2026 and what it will look like in 2027.

These are the twelve. This is what each one does, where each one operates, what each one is currently dealing with, and what you should know going in.

1. Curaleaf Holdings

Listing: Toronto Stock Exchange (CURA) Headquarters: Connecticut corporate offices Footprint: Operations in approximately 17 states Founder/Chair: Boris Jordan, with longstanding roots in Russian and emerging-market private equity

The largest U.S. cannabis MSO by most metrics. Carries the largest accumulated debt load and the largest reported unpaid IRS tax balance among MSOs. Named in the Ohio AG cartel complaint. Active proponent of the federal litigation strategy challenging 280E and CSA application to state-legal cannabis. Significant IIPR tenant exposure.

What you should know: Curaleaf's scale is the strategic moat that allows it to absorb pressures that smaller operators cannot. It is also the source of the antitrust exposure now materializing in Ohio. Investor materials emphasize the operational scale. The cartel allegations characterize that scale differently.

2. Trulieve Cannabis Corp.

Listing: Canadian Securities Exchange (TRUL) Headquarters: Tallahassee, Florida Footprint: Florida-anchored, with operations in Arizona, Connecticut, Georgia, Maryland, Massachusetts, Ohio, Pennsylvania, West Virginia CEO: Kim Rivers (co-founder)

Florida medical cannabis market leader. The company's Florida concentration produces dependency dynamics — Florida market trends substantially drive corporate performance. Named in the Ohio AG cartel complaint. Significant IIPR tenant exposure. CEO compensation has been among the higher MSO packages in recent years.

What you should know: Trulieve's Florida moat is real but increasingly contested. Florida political dynamics, vertical integration regulatory framework, and competitive entry pressures all matter for the company's future. The Ohio cartel allegations add multi-state legal exposure.

3. Green Thumb Industries

Listing: Canadian Securities Exchange (GTII) Headquarters: Chicago, Illinois Footprint: Operations in 14+ states including major markets Founder/CEO: Ben Kovler

Generally considered the best-managed of the major MSOs by financial discipline and operating margin. Less leveraged than peers, more conservative in expansion bets, better operating performance through industry downturns. Operates the RISE Dispensaries retail brand. Named in the Ohio AG cartel complaint despite the favorable management reputation.

What you should know: Green Thumb's operating discipline is real but does not insulate it from antitrust exposure if the conduct alleged in the Ohio complaint is proven. The company's stronger balance sheet positions it to acquire distressed assets in the current cycle.

4. Cresco Labs

Listing: Canadian Securities Exchange (CL) Headquarters: Chicago, Illinois Footprint: Operations in 9+ states including California, Florida, Illinois, Maryland, Massachusetts, Michigan, Ohio, Pennsylvania Co-founder/CEO: Charlie Bachtell

Built initial position on Illinois cannabis dominance. Operates the Sunnyside dispensary chain plus Cresco-branded cannabis products. Named in the Ohio AG cartel complaint. Faces operating challenges from price compression and refinancing pressures comparable to peer MSOs.

What you should know: Cresco's Illinois market dominance has been the strategic anchor; California and other expansion has been less consistently successful. The Ohio cartel allegations create additional operational and legal complexity.

5. Verano Holdings

Listing: Canadian Securities Exchange (VRNO) Headquarters: Chicago, Illinois Footprint: Operations in 13+ states Founder/CEO: George Archos

Operates the Zen Leaf retail chain plus a portfolio of cannabis brands. Has built significant cultivation and processing infrastructure across its multi-state footprint. Named in the Ohio AG cartel complaint. Refinancing pressures comparable to peer MSOs.

What you should know: Verano has been less prominent in industry conversation than the largest MSOs but operates at scale comparable to several of them. The cartel allegations apply with similar force.

6. Ascend Wellness Holdings

Listing: Canadian Securities Exchange (AAWH) Headquarters: New York / New Jersey Footprint: Operations in Illinois, Massachusetts, Michigan, New Jersey, Ohio, Pennsylvania Founder/CEO: Abner Kurtin (background in Ashvale Inc.)

The most public proponent of the MSO federal litigation strategy challenging 280E and CSA application. CEO Kurtin has publicly committed the company to suing the federal government over cannabis policy. Named in the Ohio AG cartel complaint. Significant IIPR tenant exposure with leases on roughly 624,000 square feet.

What you should know: Ascend's litigation strategy is high-profile and high-stakes. The company is essentially betting on legal outcomes that may or may not arrive in time to support the company's debt service and operational needs.

7. Glass House Brands

Listing: NEO Exchange (GLAS.A.U) Headquarters: Long Beach, California Footprint: Primarily California, with greenhouse cultivation as strategic anchor Co-founders: Kyle Kazan and Graham Farrar

The most California-anchored of the major MSOs. Strategy centers on large-scale greenhouse cultivation in Ventura County, producing cannabis at unit costs other MSO models struggle to match. Named in the Ohio AG cartel complaint despite the primarily California focus. Better-performing public cannabis stock than most peers in recent years.

What you should know: The greenhouse model is genuinely differentiated and the company's relative financial position is stronger than most peers. The Ohio cartel allegations are unexpected given the California focus and worth watching for additional context.

8. Schwazze (Medicine Man Technologies)

Listing: OTCQX (SHWZ) Headquarters: Denver, Colorado Footprint: Colorado-anchored, with operations in New Mexico CEO: Justin Dye (background in retail and consumer goods)

Mountain West regional consolidator. Less prominent in national MSO discourse than larger peers. Active in acquiring cannabis assets in Colorado and adjacent states with regional rollup strategy. Named in the Ohio AG cartel complaint despite the regional focus.

What you should know: Schwazze's regional strategy has produced more consistent performance than some national MSO models, but the Colorado market has been challenging for all operators in recent years.

9. PharmaCann

Status: Privately held Headquarters: Chicago, Illinois Footprint: Operations in Illinois, Massachusetts, Maryland, New York, Ohio, Pennsylvania CEO: Brett Novey

The only privately-held company in the top tier. Less public information available compared to publicly-listed peers. Defaulted on $29 million in annual rent obligations to IIPR in 2025, signaling acute financial stress. Named in the Ohio AG cartel complaint.

What you should know: PharmaCann's private status limits transparency. The IIPR default is meaningful. The Ohio cartel allegations add to existing financial stress.

10. The Cannabist Co. (Formerly Columbia Care)

Status: Bankruptcy filings (March 2026) Headquarters: Various (in process of restructuring) Footprint: Was operating in roughly 18 states; now substantially reduced

Filed for Chapter 11 in U.S. Bankruptcy Court in Delaware in March 2026 with parallel Canadian proceedings. Owes $270M+ to lenders and the IRS. Has sold or surrendered licenses in Virginia, Ohio, Delaware, and New York. Selling additional state operations.

What you should know: The Cannabist filing is the first major MSO bankruptcy and serves as the test case for how cannabis MSO restructurings work. Watching the case is essential for understanding what is likely coming for other distressed MSOs.

11. TerrAscend

Listing: Canadian Securities Exchange (TER) Headquarters: Toronto, Ontario (Canadian incorporation) Footprint: Operations in Pennsylvania, New Jersey, Michigan, Maryland, Ohio, and other markets Significant Stakeholders: Canopy Growth has held investment positions

Cross-border operator with significant Canadian operational and corporate connections. Active proponent of MSO federal litigation strategy alongside Ascend Wellness and Curaleaf. Faces refinancing and operational pressures comparable to peer MSOs.

What you should know: TerrAscend's cross-border structure adds complexity to its corporate finance and regulatory exposure. The federal litigation strategy is shared with the largest MSO peers.

12. Cresco / Innovative Industrial Properties (For Reference)

Note: IIPR is technically a REIT (real estate investment trust), not an operating MSO, but its impact on the MSO sector is so substantial that it belongs on any honest list of dominant cannabis sector entities.

Listing: NYSE (IIPR) Headquarters: San Diego, California Role: Sale-leaseback REIT serving cannabis operators

Tenant base concentrated among top MSOs. Tenants include Ascend Wellness ($31.3M annual rent), PharmaCann ($29.1M, defaulted), Green Thumb Industries ($23M), Curaleaf ($21M), Trulieve ($20M), 4Front Ventures ($18M, defaulted), and others. Stock price has declined substantially from 2021 peaks reflecting tenant credit deterioration.

What you should know: IIPR's relationship with its MSO tenants is a major variable in cannabis sector economics. Tenant defaults affect IIPR; IIPR responses affect tenants; the dynamics shape the industry's capital structure.

What Knowing the Twelve Means

These twelve entities collectively control the bulk of regulated cannabis retail, cultivation, and processing in the United States. Their decisions shape what brands consumers see on shelves, what wages workers earn, what political agendas industry trade associations pursue, and what futures are possible for the smaller operators trying to compete.

Understanding the twelve is the foundation for understanding cannabis industry dynamics generally. The Ohio cartel allegations apply to nine of them. The debt wall affects most of them. The tax non-payment strategy is being run by several of them. The bankruptcy precedent has been set by one of them. The future of all of them is being determined now by federal regulatory decisions, lender behavior, and the ability of each to survive the contraction underway.

If you patronize cannabis retail, you are almost certainly transacting with one of these twelve entities. If you work in cannabis, you are likely working for, against, or alongside one of them. If you regulate cannabis, you are dealing with their lobbyists. If you compete with cannabis, they are your competitors.

Know the players. Know what they're doing. Know what's coming next. The cannabis industry that exists is, substantially, the industry these twelve entities have built. The cannabis industry that emerges from the current contraction will be shaped by which of them survive, which fail, and what the surviving ones do with the consolidation opportunity in front of them.

The list is not flattering to the industry. It is also not optional knowledge for anyone who wants to understand it.

---

Internal links:

• The MSO Cartel: Inside the Price-Fixing Lawsuit →
• Curaleaf, Trulieve, Green Thumb: The MSOs Named in the Ohio Cartel Suit →
• The Cannabist Bankruptcy →